Minimal Residual Disease (MRD) Status Following Induction Chemo-Immunotherapy Predicts Progression-Free Survival In Mantle Cell Lymphoma (MCL): CALGB 50403 (Alliance)
- Citation:
- Blood vol 122 (21) Abstract 3002
- Meeting Instance:
- ASH 2013
- Year:
- 2013
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3168
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Noreen Fulton Jeffrey Johnson Lawrence D. Kaplan Greg Koval Greg Malnassy Sin-Ho Jung Steve Devine Thomas C. Shea John P. Leonard Bruce D. Cheson Wendy Stock
- Networks:
- Study
- CALGB-50403
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: